Injective (INJ) is currently trading at $2.84, reflecting a 24-hour decline of 2.16%. The daily trading range has been narrow, with a high of $2.92 and a low of $2.84, indicating limited volatility in the short term.

The trading volume stands at approximately 31.8 million, translating to a volume-to-market cap ratio of 11.20%, which suggests moderate liquidity. However, the downward price movement is corroborated by various moving averages, with the 8 SMA at $2.89 and the 144 SMA at $3.02, indicating a bearish trend in the short to medium term.

The 1-hour RSI is currently at 34, entering oversold territory, while the 7-day RSI is at 46, suggesting a lack of bullish momentum. The price performance over the past week, 14 days, and 30 days shows declines of approximately 6.44%, 24.01%, and 7.39%, respectively, underscoring a sustained bearish sentiment.

Injective's all-time high of $52.62 remains far above its current price, indicating significant room for recovery but also a challenging environment for bullish investors. The substantial price drop from its all-time high suggests that the market may be experiencing strong resistance levels and could face further downward pressure in the near term.

Given the combination of bearish technical indicators, declining RSI values, and a lack of positive momentum, the recommendation for Injective (INJ) is to Hold. This strategy allows investors to assess potential reversals or further declines while avoiding losses in a bearish market.